14 – FDA 21 CFR Part 211 Returned and Salvaged Drug Products (S14E11)

From Concept to Medicine - A Comprehensive Drug Development Journey

This episode delves into Subpart K of 21 CFR Part 211, which provides specific guidance for the handling of returned and salvaged drug products. We explain the regulatory expectations for the inspection, segregation, and documentation of returned items. Furthermore, we explain how the regulation ensure that any product re-entering the supply chain does not compromise safety or efficacy. We present a risk based approach.

The episode emphasizes the importance of a risk-based approach and detailed recordkeeping to justify decisions on product disposition in compliance with GMP standards. We explore real-world examples of how companies handle returned products and the challenges they face in determining whether a product can be safely returned to the market. The discussion highlights the critical role of Subpart K in protecting the integrity of the drug supply chain and safeguarding patient health. The goal is to make sure no bad products are reintroduced.

More description

This episode delves into Subpart K of 21 CFR Part 211, which provides specific guidance for the handling of returned and salvaged drug products. We explain the regulatory expectations for the inspection, segregation, and documentation of returned items. Furthermore, we explain how the regulation ensure that any product re-entering the supply chain does not compromise safety or efficacy. We present a risk based approach.

The episode emphasizes the importance of a risk-based approach and detailed recordkeeping to justify decisions on product disposition in compliance with GMP standards. We explore real-world examples of how companies handle returned products and the challenges they face in determining whether a product can be safely returned to the market. The discussion highlights the critical role of Subpart K in protecting the integrity of the drug supply chain and safeguarding patient health. The goal is to make sure no bad products are reintroduced.

2025-05-10 21 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.